1. Home
  2. UTSI vs MIRA Comparison

UTSI vs MIRA Comparison

Compare UTSI & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTSI
  • MIRA
  • Stock Information
  • Founded
  • UTSI 1991
  • MIRA 2020
  • Country
  • UTSI China
  • MIRA United States
  • Employees
  • UTSI N/A
  • MIRA N/A
  • Industry
  • UTSI Telecommunications Equipment
  • MIRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTSI Telecommunications
  • MIRA Health Care
  • Exchange
  • UTSI Nasdaq
  • MIRA Nasdaq
  • Market Cap
  • UTSI 24.9M
  • MIRA 26.5M
  • IPO Year
  • UTSI 2000
  • MIRA 2023
  • Fundamental
  • Price
  • UTSI $2.28
  • MIRA $1.29
  • Analyst Decision
  • UTSI
  • MIRA Strong Buy
  • Analyst Count
  • UTSI 0
  • MIRA 1
  • Target Price
  • UTSI N/A
  • MIRA $17.00
  • AVG Volume (30 Days)
  • UTSI 6.0K
  • MIRA 804.3K
  • Earning Date
  • UTSI 08-29-2025
  • MIRA 11-11-2025
  • Dividend Yield
  • UTSI N/A
  • MIRA N/A
  • EPS Growth
  • UTSI N/A
  • MIRA N/A
  • EPS
  • UTSI N/A
  • MIRA N/A
  • Revenue
  • UTSI $9,793,000.00
  • MIRA N/A
  • Revenue This Year
  • UTSI N/A
  • MIRA N/A
  • Revenue Next Year
  • UTSI N/A
  • MIRA N/A
  • P/E Ratio
  • UTSI N/A
  • MIRA N/A
  • Revenue Growth
  • UTSI N/A
  • MIRA N/A
  • 52 Week Low
  • UTSI $1.84
  • MIRA $0.73
  • 52 Week High
  • UTSI $3.22
  • MIRA $2.56
  • Technical
  • Relative Strength Index (RSI)
  • UTSI 44.88
  • MIRA 40.50
  • Support Level
  • UTSI $2.15
  • MIRA $1.19
  • Resistance Level
  • UTSI $2.55
  • MIRA $1.72
  • Average True Range (ATR)
  • UTSI 0.15
  • MIRA 0.10
  • MACD
  • UTSI -0.03
  • MIRA -0.01
  • Stochastic Oscillator
  • UTSI 19.21
  • MIRA 18.25

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: